Reviewing Outcomes for HFpEF With SGLT2 Inhibitors: A Data Deep Dive

Drs Coats and Anker discuss the latest data with SGLT2 inhibitors for patients with HFpEF and other HF syndromes. Credit available for this activity expires: 12/23/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/965158?src=mkm_podcast_addon_965158